Efficacy and Safety of Basiliximab in HCV+ Patients Undergoing Liver Transplantation, as Compared With Steroids, Both Given in Combination With Cyclosporine and Mycophenolate Mofetil (MMF).
Phase of Trial: Phase III
Latest Information Update: 31 Aug 2010
At a glance
- Drugs Basiliximab; Ciclosporin; Corticosteroids; Mycophenolate mofetil
- Indications Liver transplant rejection
- Focus Therapeutic Use
- Sponsors Novartis
- 31 Aug 2010 Actual end date (Jul 2005) added as reported by ClinicalTrials.gov.
- 28 Dec 2005 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History